ARCHIVES

Raloxifene Protects Women At High or Low Risk of Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

CAP, ASCCP Recommendations Standardize Lesion Terminology

July 27, 2012

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984

Clinical Research: Cooperative Groups Form Coalition to Advance Trials

November 14, 1997

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

HHS Group To Study Policies Affecting Academic Centers

June 20, 1997